The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells
Antje Ludwig(Humboldt-Universität zu Berlin), Verena Stangl(Deutsches Herzzentrum der Charité), Mario Lorenz(Humboldt-Universität zu Berlin), Silke Meiners(Christian-Albrechts-Universität zu Kiel), Cornelia Bartsch(Humboldt-Universität zu Berlin), Nicole Grimbo(Humboldt-Universität zu Berlin), Gert Baumann(Charité - Universitätsmedizin Berlin), Karl Stangl(German Centre for Cardiovascular Research), Frederike Steinle(Humboldt-Universität zu Berlin)
Cited by 196
Related Papers
Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial
|The Lancet|2018|734
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study
|European Heart Journal|2017|334
A Constituent of Green Tea, Epigallocatechin-3-gallate, Activates Endothelial Nitric Oxide Synthase by a Phosphatidylinositol-3-OH-kinase-, cAMP-dependent Protein Kinase-, and Akt-dependent Pathway and Leads to Endothelial-dependent Vasorelaxation
|Journal of Biological Chemistry|2004|332
Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases
|European Heart Journal|2005|274
Molecular targets of tea polyphenols in the cardiovascular system
|Cardiovascular Research|2006|241